Cita APA

Kudo‐Fujimaki, K., Hirose, T., Yoshihara, T., Sato, F., Someya, Y., Ohmura, C., . . . Watada, H. (2013). Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide. Wiley-Blackwell.

Chicago Style Citation

Kudo‐Fujimaki, Kyoko, Takahisa Hirose, Tomoaki Yoshihara, Fumihiko Sato, Yuki Someya, Chie Ohmura, Akio Kanazawa, Yoshio Fujitani, i Hirotaka Watada. Efficacy and Safety of Nateglinide Plus Vildagliptin Combination Therapy Compared With Switching to Vildagliptin in Type 2 Diabetes Patients Inadequately Controlled With Nateglinide. Wiley-Blackwell, 2013.

Cita MLA

Kudo‐Fujimaki, Kyoko, et al. Efficacy and Safety of Nateglinide Plus Vildagliptin Combination Therapy Compared With Switching to Vildagliptin in Type 2 Diabetes Patients Inadequately Controlled With Nateglinide. Wiley-Blackwell, 2013.